CONMED Withdraws FY22 Guidance Due To Disruptions Associated With Software Implementation

Vandana Singh
1 min read
0
In this article:

  • CONMED Corp (NYSE: CNMD) is withdrawing its FY22 financial outlook, citing a temporary disruption resulting from implementing new warehouse management software.

  • In recent weeks, the company began implementing new software designed to increase the efficiency and performance of its primary distribution facility.

  • The implementation of this new software created shipping disruptions that lasted longer than initially projected.

  • CONMED cannot fully assess the impact on fourth-quarter sales and profitability as it continues to incur costs while working to reduce the shipping backlog.

  • Daily shipment volumes have returned to normal levels, and the company has reduced the shipping backlog from a peak of approximately $35 million last week to approximately $28 million today.

  • CONMED believes the backlog of open orders will be shipped in the coming weeks and anticipates the impact on business performance will be limited to the fourth quarter of 2022.

  • CONMED expected FY22 sales of $1.1-$1.115 billion, with adjusted EPS of $3.21-$3.28, versus the consensus of $1.11 billion and $3.28, respectively.

  • For the full-year 2023, the company expects reported revenue of $1.170-$1.230 billion (consensus $1.21 billion) and adjusted EPS of $3.20-$3.50 (consensus $3.39).

  • Price Action: CNMD shares traded higher by 1.96% at $90.84 on the last check Tuesday.

See more from Benzinga

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Advertisement

Recommended Stories